National Health Institute of Nouvelle Alexandrie
The National Health Institute (Alexandrian: Institute National de la Santé) or INS is the primary agency of Nouvelle Alexandrie responsible for biomedical and public health research. It is part of the Department of Social Security and National Solidarity. It oversees a total of 15 centers of expertise that carry out is mission in all areas of biomedical research.
The INS conducts its scientific research as part of the General Directorate through its INS Research Program. It further provides funding to significant biomedical research for non-INS research facilities through the Allied Biomedical Program. As of 1738 AN, the INS has over 2,400 principal investigators and more than 6,500 postdoctoral fellows in basic, translational, and clinical research, while the external funding provides over 19% of all annual biomedical research funding, over €10.2 billion. Basic research contributes to over 75% of all new drug approvals by the National Food and Drug Agency. It has historically been the largest contributor to biomedical sciences in Nouvelle Alexandrie, and one of the top 5 in the world.
History
The INS was founded by the Department of Social Security and National Solidarity in 1686 AN to consolidate the disparate efforts of Nouvelle Alexandrie in biomedical research. It adsorbed at that time three pre-existing organisations:
- Scientific Review Board
- Centre for Healthcare Ethics
- Federal Center for Cancer Research
- Office of Disease Prevention
- Office of Biotechnology
At that time, INS was headquartered in Parap, the capital of Wechua Nation. It moved into its current headquarters at Vida Science Park, Cárdenas, in 1690 AN. Over the years that followed, it opened up a total of 14 new science centers, ranging from neurology, infectious disease, to genetics. It also established a total of 8 new associated operating groups to assist the efforts of medical science.
Over the years, INS has been instrumental in the discovery of novel drugs; research into epidemics such as AIDS; and innovation in medical technology. It has also been involved, since 1707 AN, with research on the Human genome; advanced proteomic sequencing; and treatment of addiction.
Organization
The INS is overseen by the General Directorate, the central office of the organization. It is responsible for setting policy for the institute, and overseeing, administrating, and planning the programs and activities of all INS components. The Directorate has several Mission Offices, which aid in specific areas of research for all divisions.
- Mission Office for Behavioral and Social
- Mission Office for Dietary Needs
- Mission Office for Indigenous and Tribal Health Research
- Mission Office for Sexual and Gender Minority Research
- Mission Office for STDs
- Mission Office for Women's Health
The Office of Planning,Program Coordination, and Strategy is directly responsible for overseeing the planning and execution of biomedical research under the INS institutes, as well as ensuring integrity within the institutes and associated groups. The Office of Finances is directly responsible for managing the funding of the INS internal and external programs.
Research
In 1738 AN, INS dedicated about 20% of its total funding to research within its own facilities, and gave more than 80% in research grants to external researchers. Of this funding, more than 8% is spend specifically on small businesses, and an additional 4% on minority-owned businesses. In 1738 AN, more than 80,000 grants were given to over 500,000 researchers at over 2500 institutions. In 1738 AN, the INS spent €28.1 billion on clinical research, €4.8 billion on genetics research, €6.7 billion on prevention research, €4 billion on cancer, and €6.5 billion on biotechnology.
Library of Medicine
The Federal Library of Medicine, established in 1692 AN, provides principal investigators and the general public with free access to research papers published by the INS and grantees of its external program. It has an open access policy that mandates that all electronic versions are publicly available no later than 12 months after publishing. It is the largest national repository for biomedical research.
National Genetic Databank
The Federal Center for the Human Genome hosts the National Genetic Databank, a repository of information produced by studies investigating the human genome. The information includes genotypes, molecular assay data, analyses, and documents. Summary-level data is available to the general public whereas the individual-level data is accessible only to researchers.
INS Toolbox
The Federal Center for General Medical Sciences has developed the INS Toolbox since 1708 AN, a state-of-the-art evaluation method to enhance collection of data in large clinical studies. This has allowed INS institutes and external grantees to perform standardized clinical trials to speed up drug discovery, approval, and commercialization.
Interagency Program
The National Interagency Program is a task force established in 1705 AN that works to integrate biomedical research and innovation between the different institutes of the INS, thereby preventing redundancy, improving collaboration, and speeding up commercialization and publishing of medical research.
